Chart of the Month

The top players in the trauma space are growing in line with historical averages despite a choppy operating environment in...

The top ten most acquisitive orthopedic companies since 2016 are more focused on technology than the rest of the market....

While orthopedic growth rates slowed in the first half of 2024, the market's volume and demand remain healthy....

Through the first half of 2024, orthopedic investment activity is on pace for a rebound and one of its busiest...

The increasing importance of technology ecosystems in the spine market could mean that a large population of smaller companies are...

Enovis' reconstructive segment accounted for just 22% of sales in 2019. It will account for nearly 50% as it reaches...

According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023....

While Orthofix's trauma business is growing slower than the market, it has an enormous opportunity in the U.S....

Backlogged procedures drove much of the robust demand for joint replacement in 2023 but more durable tailwinds could also be...

We expect around 30 orthopedic M&A transactions in 2024 with activity remaining focused on spine-related assets....